Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

EG434676 Activators

Scgb1b19, a member of the secretoglobin family, is predicted to play a crucial role in steroid binding activity, with its activity primarily localized in the extracellular region. The protein's function is intricately linked to specific signaling pathways and cellular processes that regulate its expression and activation. To explore its activation mechanisms, we examined various chemical activators, both direct and indirect. Direct activators such as Retinoic Acid, Forskolin, Butyrate, and Quercetin were identified. Retinoic Acid, for instance, activates Scgb1b19 by binding to nuclear receptors, influencing the RAR/RXR pathway. This interaction promotes transcription, leading to increased protein levels and steroid binding activity. On the other hand, indirect activators like Curcumin and Sulforaphane modulate pathways like NF-κB and Nrf2, respectively, affecting Scgb1b19 expression and steroid binding activity.

Furthermore, chemicals like Lithium Chloride and Eicosapentaenoic Acid (EPA) were found to act indirectly by influencing pathways such as the Wnt and PPARγ pathways, respectively. These chemicals, by modulating specific cellular processes, ultimately enhance Scgb1b19 expression and contribute to increased steroid binding activity. In summary, Scgb1b19's activation is intricately tied to the modulation of various pathways and cellular processes by specific chemicals. The identified activators, both direct and indirect, offer valuable insights into the molecular mechanisms governing Scgb1b19 expression and its vital role in steroid binding activity within the extracellular environment.

SEE ALSO...

Items 11 to 11 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

α-Lipoic Acid

1077-28-7sc-202032
sc-202032A
sc-202032B
sc-202032C
sc-202032D
5 g
10 g
250 g
500 g
1 kg
$69.00
$122.00
$212.00
$380.00
$716.00
3
(1)

Alpha-Lipoic Acid indirectly activates Scgb1b19 by modulating the Nrf2 pathway. Nrf2 activation enhances Scgb1b19 expression, resulting in an upregulation of steroid binding activity in the extracellular region.